Share on StockTwits

Research Analysts’ ratings reiterations for Friday, August 15th:

Agilent Technologies (NYSE:A) had its neutral rating reiterated by analysts at Zacks. Zacks currently has a $58.00 price target on the stock. Zacks’ analyst wrote, “Agilent Technologies is a broad-based OEM of test and measurement equipment. The company’s third quarter earnings were above the Zacks Consensus Estimate. Agilent’s focus has shifted to life sciences, genomics, diagnostics and wireless test markets, where the company has made a few important acquisitions. The Electronic Measurement spin-off should reduce the cyclicality of the business. However, the macro weakness in the U.S. and Europe may temper revenue growth with the significant increase in operating expenses impacting the bottom line. We therefore have a Neutral recommendation on Agilent shares.”

Achillion Pharmaceuticals (NASDAQ:ACHN) had its buy rating reaffirmed by analysts at Maxim Group.

Acura Pharmaceuticals (NASDAQ:ACUR) had its buy rating reissued by analysts at Roth Capital. They currently have a $1.50 target price on the stock, down from their previous target price of $2.50.

Applied Materials (NASDAQ:AMAT) had its neutral rating reiterated by analysts at Zacks. The firm currently has a $22.00 price target on the stock. Zacks’ analyst wrote, “Applied Materials is one of the world’s largest suppliers of fabrication equipment to semiconductor, LCD and solar PV cell manufacturers. Applied’s third quarter earnings were above the Zacks Consensus Estimate by a penny. However, the guidance was in line with expectations. The proliferation of mobile devices, strength in mobility platforms, TV capacity builds, better utilization of resources and the recently-announced merger with Tokyo Electron are positives. Of course, the high cost structure and customer concentration are things to be cautious about. We therefore have a Neutral recommendation on Applied Materials shares.”

BAE Systems PLC (NASDAQ:BAESY) had its buy rating reissued by analysts at Espirito Santo Investment Bank Research.

Briggs & Stratton Corp. (NYSE:BGG) had its sell rating reiterated by analysts at Off Wall Street.

Energy XXI (Bermuda) Limited (NASDAQ:EXXI) had its buy rating reaffirmed by analysts at Canaccord Genuity. Canaccord Genuity currently has a $30.00 price target on the stock, down from their previous price target of $36.00.

Energy XXI (Bermuda) Limited (NASDAQ:EXXI) had its buy rating reissued by analysts at KLR Group. The firm currently has a $24.00 price target on the stock, up from their previous price target of $6.00.

K12 (NYSE:LRN) had its market perform rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $20.00 price target on the stock.

Las Vegas Sands Corp. (NYSE:LVS) had its buy rating reissued by analysts at Sterne Agee. They currently have a $84.00 price target on the stock, down from their previous price target of $92.00.

Melco Crown Entertainment Ltd (NASDAQ:MPEL) had its buy rating reaffirmed by analysts at Sterne Agee. Sterne Agee currently has a $54.00 target price on the stock, down from their previous target price of $57.00.

NPS Pharmaceuticals (NASDAQ:NPSP) had its buy rating reiterated by analysts at Canaccord Genuity.

OmniVision Technologies (NASDAQ:OVTI) had its buy rating reiterated by analysts at S&P Equity Research. They currently have a $8.92 target price on the stock, down from their previous target price of $15.07. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

PDI (NASDAQ:PDII) had its buy rating reaffirmed by analysts at Roth Capital. They currently have a $6.50 target price on the stock, down from their previous target price of $8.00.

Red Robin Gourmet Burgers (NASDAQ:RRGB) had its buy rating reissued by analysts at Wunderlich. Wunderlich currently has a $92.00 price target on the stock, up from their previous price target of $76.00.

Reed Elsevier plc (NYSE:RUK) had its neutral rating reaffirmed by analysts at Credit Suisse.

Symantec (NASDAQ:SYMC) had its hold rating reissued by analysts at Topeka Capital Markets. They currently have a $25.50 price target on the stock, up from their previous price target of $24.00.

Wynn Resorts, Limited (NASDAQ:WYNN) had its buy rating reaffirmed by analysts at Sterne Agee. They currently have a $245.00 target price on the stock, down from their previous target price of $260.00.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.